1)Coats G:Forms of retinal diseases with massive exudation. Roy Lond Ophthalmol Hosp Rep 17:440-525, 1908
2)Shields JA, Shields CL, Honavar SG et al:Classification and management of Coats disease:the 2000 Proctor Lecture. Am J Ophthalmol 131:572-583, 2001
3)Shienbaum GB, Tasman WS:Coats disease:a lifetime disease. Retina 26:422-424, 2006
4)Sun Y, Lain A, Moshfeghi et al:Elevated vascular endothelial growth factor levels in Coats' disease:rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 245:1387-1388, 2007
5)Lin CJ, Hwang JF, Chen SN:The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina 30:617-622, 2010
6)Stergiou PK, Symeonidis C, Dimitrakos SA:Coats' disease:treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol 87:687-688, 2009
7)Kaul S, Uparkar M, Mody K et al:Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children. Indian J Ophthalmol 58:76-78, 2010
8)Shields JA, Shields CL:Coats disease:The 2001 Luesther T Mertz lecture. Retina 22:80-91, 2002
9)He YG, Wang H, Zhao B et al:Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol 248:1519-1521, 2010